Riskpilot← Back to searchSign inGet full accessVitrolife AB
ABActiveOrg 5563543452Gustaf Werners Gata 2Activities of holding companies · NACE 6421Est. 19891 employees
Revenue 2024
SEK 25M
-47% vs 2023
EBITDA margin
-88.0%
-29% vs 2023
Equity ratio
79.3%
Financial strength
Net profit 2024
SEK 140M
+105% vs 2023
| Revenue | SEK 25M | -47% |
| EBITDA | SEK -22M | -29% |
| Net profit | SEK 140M | +105% |
| Total assets | SEK 15,1B | +4% |
| Equity | SEK 12B | +0% |
| Employees | 1 | — |
Legal name
Vitrolife AB
Org number
5563543452
Legal form
Aktiebolag
NACE code
6421 · Activities of holding companies
Founded
2 mars 1989
Share capital
SEK 28 000 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Firman tecknas av Brophy O'Connor, Bronwyn Anne i förening med en av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva forskning, utveckling, produktion och försäljning av biomedicinska lösningar och läkemedel samt idka därmed förenlig verksamhet.
Address
Gustaf Werners Gata 2
Phone
+46317218000
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 19 130 | 24 537 | 42 000 | 47 000 | 25 000 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −2 267 | −8 434 | −13 000 | −17 000 | −22 000 |
| Depreciation & amort. | — | — | — | — | — |
| EBIT | −2 267 | −8 434 | −13 000 | −17 000 | −22 000 |
| Net financials | 967 | 701 075 | −48 000 | −5 837 000 | −73 000 |
| Profit before tax | 2 924 | 772 962 | 213 000 | −2 708 000 | 155 000 |
| Tax | 2 292 | −12 812 | −11 000 | −15 000 | −15 000 |
| Net profit | 5 216 | 760 150 | 202 000 | −2 723 000 | 140 000 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 097 110 | 17 323 013 | 17 235 000 | 14 565 000 | 15 082 000 |
| Equity | 954 375 | 14 664 499 | 14 768 000 | 11 946 000 | 11 962 000 |
| Long-term debt | 0 | 1 923 966 | 1 988 000 | 1 897 000 | 1 878 000 |
| Short-term debt | 133 890 | 723 628 | 465 000 | 722 000 | 1 216 000 |
| Total debt | 133 890 | 2 647 594 | 2 453 000 | 2 619 000 | 3 094 000 |
EBITDA margin
-88.0%
This company
15.8%
Market median
-657% vs market
20202024
Equity ratio
79.3%
This company
38.2%
Market median
+108% vs market
20202024
Return on equity
1.2%
This company
18.4%
Market median
-93% vs market
20202024
Net profit margin
560.0%
This company
8.1%
Market median
+6814% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.26×
This company
0.62×
Market median
+58% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
BA Chief Executive Officer | Chief Executive Officer | 2020 |
KA Chief Auditor | Chief Auditor | 2025 |
| Former (2) | ||
HC Chief Auditor | Chief Auditor | 2020 – 2025 |
FP Chief Auditor | Chief Auditor | 2020 – 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Board of Directors | 2020 | |
| Chairman | 2020 | |
| Board of Directors | 2020 | |
| Board of Directors | 2020 | |
| Board of Directors | 2020 | |
| Former (1) | ||
| Board of Directors | 2023 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Vitrolife AB (this company)
Vitrolife, Inc.Stb Zorg BvVitrolife Pty Ltd.Vitrolife KkMendel Holdco S.lA.T.S. SrlVitrolife A/SVitrolife (Beijing) Technical Service Co. Ltd.New Genetics S.lHertart ApsVitrolife BvVitrolife Ltd.Vitrolife GmbhSTB ZORG BVVITROLIFE (BEIJING) TECHNICAL SERVICE CO. LTD.A.T.S. SRLVITROLIFE GMBHVITROLIFE LTD.VITROLIFE BVVITROLIFE PTY LTD.VITROLIFE, INC.VITROLIFE A/SVITROLIFE KKNEW GENETICS S.LHERTART APSBoard members of Vitrolife AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bronwyn Anne Brophy O'Connor | Chief Executive Officer | 0 companies |
| Harald Clifford Jagner | Chief Auditor | 0 companies |
| Fredrik Pierre Roger Jonsson | Chief Auditor | 0 companies |
| Karin Anneli Madeleine Pihl | Chief Auditor | 0 companies |
| Karen Lykke Sörensen | Board of Directors | 0 companies |
| Jon Sigurdsson | Chairman | 0 companies |
| Henrik Gustaf Knutsson Blomquist | Board of Directors | 0 companies |
| Lars Erik Holmqvist | Board of Directors | 0 companies |
| Vesa Veikko Koskinen | Board of Directors | 0 companies |
| Pia Catharina Askenström Marions | Board of Directors | 0 companies |